Skip to main content

Advertisement

Log in

Levothyroxine Absorption in Morbidly Obese Patients Before and After Roux-En-Y Gastric Bypass (RYGB) Surgery

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Roux-en-Y gastric bypass (RYGB) modifies the anatomical structure of the upper intestine tract, reduces gastric acid secretion, and may impair LT4 absorption. The aim of this study was to evaluate the LT4 absorption in morbidly obese patients before and after RYGB.

Methods

Thirty morbidly obese patients were divided in two groups: The NS group included 15 patients before RYGB surgery (BMI = 43.1 ± 4 kg/m2), and the S group included 15 patients after surgery (BMI = 37.3 ± 4 kg/m2). Two baseline samples were collected, and 600 μg of oral LT4 tablets were administered. Blood samples were collected at 30, 60, 120, 180, 240, 300, and 1440 min. Serum-free T4 (FT4), total T4 (TT4), and TSH were measured at each time point. The increase in TT4, FT4, and TSH (ΔTT4, ΔFT4, and ΔTSH) was calculated, subtracting from the baseline mean value.

Results

The pharmacokinetics parameters regarding LT4 absorption, maximum ΔTT4, and area under the curve(AUC) of both ΔTT4 and ΔFT4 were significantly higher in the S group compared with the NS group (p < 0.05). It was observed, however, that there was a significant delay in the absorption of LT4 in the S group. Basal serum TSH and leptin levels were higher in the NS group (p = 0.016 and 0.026, respectively), whereas basal serum TT4, FT4, ΔTSH, and the AUC of ΔTSH were similar between groups.

Conclusions

In this study, we have demonstrated that Roux-en-Y bypass surgery does not diminish LT4 absorption. A small but significant delayed absorption of LT4, however, was observed in patients after surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 2009;115:3801–7.

    Article  PubMed  Google Scholar 

  2. Camargo RY, Tomimori EK, Neves SC, et al. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. Eur J Endocrinol. 2008;159:293–9.

    Article  PubMed  CAS  Google Scholar 

  3. Aoki Y, Belin RM, Clickner R, et al. Serum TSH and total t4 in the United States population and their association with participant characteristics: National Health And Nutrition Examination Survey (NHANES 1999–2002). Thyroid. 2007;17:1211–23.

    Article  PubMed  Google Scholar 

  4. Papavramidis ST, Zisiadis AC, Karamouzis MN, et al. Alterations in thyroid hormones and thyrotropin (TSH) in morbidly obese patients before and after vertical gastroplasty. Obes Surg. 1995;5:298–301.

    Article  PubMed  Google Scholar 

  5. Marzullo P, Minocci A, Tagliaferri MA, et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab. 2010;95:3965–72.

    Article  PubMed  CAS  Google Scholar 

  6. Sherman SI, Malecha SE. Absorption and malabsorption of levothyroxine sodium. Am J Ther. 1995;2:814–8.

    Article  PubMed  Google Scholar 

  7. Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med. 1994;97:363–5.

    Article  PubMed  CAS  Google Scholar 

  8. Northcutt RC, Stiel JN, Hollifield JW, et al. The influence of cholestyramine on thyroxine absorption. JAMA. 1969;208:1857–61.

    Article  PubMed  CAS  Google Scholar 

  9. Sherman SI, Tielens ET, Ladenson PW. Sucralfate causes malabsorption of l-thyroxine. Am J Med. 1994;96:531–5.

    Article  PubMed  CAS  Google Scholar 

  10. Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117:1010–3.

    PubMed  CAS  Google Scholar 

  11. Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid. 2001;11:967–71.

    Article  PubMed  CAS  Google Scholar 

  12. McLean M, Kirkwood I, Epstein M, et al. Cation-exchange resin and inhibition of intestinal absorption of thyroxine. Lancet. 1993;341:1286.

    Article  PubMed  CAS  Google Scholar 

  13. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of l-thyroxine caused by coffee. Thyroid. 2008;18:293–301.

    Article  PubMed  CAS  Google Scholar 

  14. Chiu AC, Sherman SI. Effects of pharmacological fiber supplements on levothyroxine absorption. Thyroid. 1998;8:667–71.

    Article  PubMed  CAS  Google Scholar 

  15. Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:1787–95.

    Article  PubMed  CAS  Google Scholar 

  16. Checchi S, Montanaro A, Pasqui L, et al. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J Clin Endocrinol Metab. 2008;93:465–9.

    Article  PubMed  CAS  Google Scholar 

  17. Benvenga S, Bartolone L, Squadrito S, et al. Delayed intestinal absorption of levothyroxine. Thyroid. 1995;5:249–53.

    Article  PubMed  CAS  Google Scholar 

  18. Hays MT, Nielsen KR. Human thyroxine absorption: age effects and methodological analyses. Thyroid. 1994;4:55–64.

    Article  PubMed  CAS  Google Scholar 

  19. Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab. 2005;90:124–7.

    Article  PubMed  CAS  Google Scholar 

  20. Mistry D, Atkin S, Atkinson H, et al. Predicting thyroxine requirements following total thyroidectomy. Clin Endocrinol (Oxf). 2011;74:384–7.

    Article  CAS  Google Scholar 

  21. Zaninotto P, Head J, Stamatakis E, et al. Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. J Epidemiol Community Health. 2009;63:140–6.

    Article  PubMed  CAS  Google Scholar 

  22. Decker GA, Swain JM, Crowell MD, et al. Gastrointestinal and nutritional complications after bariatric surgery. Am J Gastroenterol. 2007;102:2571–80. quiz 2581.

    Article  PubMed  Google Scholar 

  23. Hays MT. Localization of human thyroxine absorption. Thyroid. 1991;1:241–8.

    Article  PubMed  CAS  Google Scholar 

  24. Hennemann G, Docter R, Friesema EC, et al. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev. 2001;22:451–76.

    Article  PubMed  CAS  Google Scholar 

  25. Wenzel KW, Kirschsieper HE. Aspects of the absorption of oral l-thyroxine in normal man. Metabolism. 1977;26:1–8.

    Article  PubMed  CAS  Google Scholar 

  26. Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes. 1986;10:245–6.

    PubMed  CAS  Google Scholar 

  27. Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med. 1979;90:941–2.

    PubMed  CAS  Google Scholar 

  28. Kok P, Roelfsema F, Langendonk JG, et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab. 2005;90:4659–63.

    Article  PubMed  CAS  Google Scholar 

  29. Flier JS, Harris M, Hollenberg AN. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest. 2000;105:859–61.

    Article  PubMed  CAS  Google Scholar 

  30. Hollenberg AN. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid. 2008;18:131–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to the patients who have consented to undergo LT4 absorption tests. We also want to express our gratitude to Suzimara A. de Oliveira from The Central Laboratory, Valeria Samuel Lando from the Endocrine Laboratory (LIM 42) for conducting the thyroid function tests and leptin measurements, and to Aché Laboratórios Farmacêuticos S.A. for the supply of LT4 tablets (Levoid®).

Disclosure Summary

This work was partially funded by a research grant from Aché Laboratórios Farmacéuticos S.A. to Fundação Faculdade de Medicina São Paulo, Brazil, a non-profit organization. A partial grant was also received from Instituto da Tiróide (São Paulo), also a non-profit organization. The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Geraldo Medeiros-Neto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubio, I.G.S., Galrão, A.L., Santo, M.A. et al. Levothyroxine Absorption in Morbidly Obese Patients Before and After Roux-En-Y Gastric Bypass (RYGB) Surgery. OBES SURG 22, 253–258 (2012). https://doi.org/10.1007/s11695-011-0452-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-011-0452-8

Keywords

Navigation